Despite falling revenues, Madison, N.J.-based Allergan’s gastroenterology franchise grew by 8.2 percent in the third quarter.
Cambridge, Mass.-based Idera Pharmaceuticals and Bermuda-based Vivelix Pharmaceuticals entered into an exclusive license and collaboration agreement.
Genetic Technologies and Australia-based University of Melbourne have entered a license agreement to develop a new colorectal cancer risk assessment test.
More articles on gastroenterology and endoscopy:
Do financial incentives promote patient adherence to CRC screening? 5 study insights
Genetic Technologies, University of Melbourne collaborate on CRC risk assessment tool: 3 notes
Outreach to cirrhosis patients increases likelihood of liver cancer screening: 3 study insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.